We develop advanced deep-tech and AI imaging software to comprehensively assess bone microarchitecture and predict fracture risk in primary and secondary osteoporosis.
Clinician friendly
Designed with clinicians in mind, our software tools seamlessly integrate into clinical routine.
Patient-centric
Non-invasive and pain-free technology requiring no additional radiation and time for patients.
Time efficient
Fast processing time
freeing-up clinicians'
time to focus on
patient care.
One step ahead of osteoporosis
TBS Reveal* is the only opportunistic AI software that assesses combined bone mass (BMD) and bone microarchitecture (Trabecular Bone Score) — Capture patients with high bone fragility earlier.
Discover the new AI-driven opportunistic bone fragility assessment from routine X-rays.
The gold standard for osteoporosis fracture risk assessment
TBS Osteo is an AI-ready technology and state-of-the-art software powered by TBS iNsight to evaluate bone microarchitecture in patients during a DXA bone densitometry scan. It provides the missing link needed to identify more patients at risk of fracture.
TBS Osteo benefits from 4 dedicated CPT® codes for Medicare beneficiaries. Reimbursement under the PFS and OPPS have steadily increased in the USA.
TBS provides additional beneficial clinical insights into fracture risk. We routinely report TBS on virtually everyone. TBS is really the first major DXA advance in years.
Prof. Neil Binkley, Department of Medicine University of Wisconsin, Madison, USA
Assessing information related to bone microarchitecture in addition to bone density and clinical risk factors provides a more complete assessment to inform management decisions for the benefit of the patient.
Prof. E. McCloskey, Department of Oncology and Metabolism at Sheffield University, UK
TBS Osteo has become the standard of care at HSS.
Dr. Elaine Cong, Endocrinologist, Hospital for Special Surgery - River Terrace, New York, USA
4.5M
worldwide procedures/year
35
guidelines
90
countries
1500
peer reviewied
medimaps group SA
Chemin du Champ-des-Filles 36A
1228 Plan-les-Ouates
Geneva, Switzerland
Medimaps Group USA LLC
1201N Market Street
Suite 111
Wilmington, DE 19801, United States
Medimaps Group has been certified by BSI to ISO 13485:2016 under certificate number MDR 799726. TBS iNsight is a trademark of Medimaps Group. TBS iNsight™ is cleared for sale in the U.S.
